Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (547) clinical trials

The primary objectives of this study are to assess the effects of RVT-101 versus placebo as adjuncts to stable donepezil therapy on cognitive function as measured by the Alzheimer’s Disease Assessment Scale - Cognitive Subscale 11 items (ADAS-Cog-11) after 24 weeks of treatment AND on activities of daily living as ...

Phase

A serial mild cognitive impairment (MCI) and Alzheimer's disease study with longitudinal measurement of cognition and biomarkers such as DNA/RNA/SERUM PLASMA/CSF

Phase N/A

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the ...

Phase

California Neuroscience Research is conducting a research study on the effectiveness and safety of an investigational medication or placebo in patients with mild Alzheimer’s disease. The study has up to 31 office visits over up to 40 months. Participants will receive an investigational medication or placebo monthly by subcutaneous injection. ...

Phase N/A

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).M

Phase N/A

52 week duration Lab testing physical exams mental scales PET and MRI scans

Phase

Researchers are conducting a local research study for an investigational drug in people with mild Alzheimer's disease.

Phase

EXPEDITION 3 will look at whether the investigational drug solanezumab can help slow the worsening of AD in patients with mild disease. Study duration will be approximately 18 months, followed by an optional open-label extension study. Participants will be randomized in a 1:1 ratio to receive solanezumab or placebo by ...

Phase

MD Clinical is conductiong a 26-week, placebo-controlled research study of the safety & efficacy of an investigational drug for Alzheimer's Disease. Study-related exams & study drugs are provided at no cost. Qualified participants & caregivers will be compensated for time & travel.

Phase N/A

Consider participating in a clinical research study to evaluate the effectivness and safety of an oral study drug that may help slow the progression of mild to moderate Alzheimer's disease. To participate, you must be 55 to 85 years old with symptoms of mental or functional decline dating back at ...

Phase N/A